SCHEMBL912134

SCHEMBL912134

CCN(C)/C=N\c1cc(C)c(Oc2ccc(Cl)c(C(C)(C)C)c2)cc1C

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 6/20 0.33
SLC6A4 P31645 6/20 0.33
KCNH2 Q12809 5/20 0.33
ESRRA P11474 2/20 0.32
SLC6A2 P23975 1/20 0.31
SLC6A3 Q01959 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2340382 1.00 HTR2A (0.33) HTR2ASLC6A4KCNH2ESRRASLC6A2
SCHEMBL912135 1.00 HTR2A (0.33) HTR2ASLC6A4KCNH2ESRRASLC6A2
SCHEMBL2336047 0.94 ESRRA (0.34) HTR2ASLC6A4KCNH2ESRRASLC6A2
SCHEMBL2336045 0.94 ESRRA (0.34) HTR2ASLC6A4KCNH2ESRRASLC6A2
SCHEMBL12710211 0.92 HTR2A (0.35) HTR2ASLC6A4KCNH2ESRRASLC6A2
SCHEMBL910774 0.91 SCN9A (0.35) HTR2ASLC6A4KCNH2ESRRA
SCHEMBL12710254 0.91 HTR2A (0.32) HTR2ASLC6A4KCNH2
SCHEMBL22176952 0.91 HTR2A (0.35) HTR2ASLC6A4KCNH2ESRRA
SCHEMBL910773 0.91 SCN9A (0.35) HTR2ASLC6A4KCNH2ESRRA
SCHEMBL3299887 0.91 SCN9A (0.35) HTR2ASLC6A4KCNH2ESRRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2014167-A1 Active compound combinations Bayer CropScience AG (DE) 2009-01-14 EP claimed
US-20110003689-A1 USE OF POLYMERIC GUANIDINE DERIVATIVES FOR THE CONTROL OF UNWANTED MICROORGANISMS IN CROP PROTECTION AKA TECHNOLOGY GMBH (AT) 2011-01-06 US disclosed
EP-2230915-A2 USE OF POLYMER GUANIDINE DERIVATIVES FOR COMBATING UNDESIRED MICROORGANISMS IN PEST MANAGEMENT Aka Technology Gmbh (AT) 2010-09-29 EP disclosed
WO-2009077098-A2 USE OF POLYMER GUANIDINE DERIVATIVES FOR COMBATING UNDESIRED MICROORGANISMS IN PEST MANAGEMENT BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2009-06-25 WO disclosed
EP-2071954-A1 Use of polymeric guanidine derivatives for combating unwanted micro-organisms in the protection of plants Bayer CropScience AG (DE) 2009-06-24 EP disclosed
EP-2014167-A1 Active compound combinations Bayer CropScience AG (DE) 2009-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003689-A1 USE OF POLYMERIC GUANIDINE DERIVATIVES FOR THE CONTROL OF UNWANTED MICROORGANISMS IN CROP PROTECTION GDA, GMPS, GANC HTR2A 2990/4885SLC6A4 3186/4885KCNH2 2368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.